ArticleFrontiers in immunology2026

Integrating inflammatory and coagulation biomarkers for surgical risk stratification and treatment benefit assessment in Crohn's disease.

Kailing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.